Literature DB >> 19680262

Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.

J Silke1, R Brink.   

Abstract

There have been a number of recent discoveries relating to the functions of inhibitors of apoptosis (IAPs) and TNF receptor-associated factors (TRAFs) in regulating signalling from TNF receptor superfamily (TNFRSF) members and some tantalizing glimpses into a wider area of influence, that of innate immune signalling. Discoveries relating to the function of these ubiquitin E3 ligases in regulating signalling from the eponymous member of the family, TNF-R1, are dealt with superbly in a separate review by Wertz and Dixit and so we will confine our discussion to the subset of the TNFRSF that does not contain a death domain (DD). In line with the available data we will divide the review into two parts, the first is restricted to the role of TRAFs 2 and 3 and cIAPs in regulating TNFRSF signalling, whereas the second will be more speculative, asking what role IAPs and TRAFs have in innate immune signalling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19680262     DOI: 10.1038/cdd.2009.114

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  48 in total

Review 1.  "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NF-kappaB activation.

Authors:  Jérémie Gautheron; Gilles Courtois
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

2.  Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.

Authors:  Rebecca Feltham; Maryline Moulin; James E Vince; Peter D Mace; Wendy Wei-Lynn Wong; Holly Anderton; Catherine L Day; David L Vaux; John Silke
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

3.  In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8.

Authors:  Ian E Gentle; W Wei-Lynn Wong; Joseph M Evans; Alexandra Bankovacki; Wendy D Cook; Nufail R Khan; Ulrich Nachbur; James Rickard; Holly Anderton; Maryline Moulin; Josep Maria Lluis; Donia M Moujalled; John Silke; David L Vaux
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

Review 4.  TWEAK and TRAF6 regulate skeletal muscle atrophy.

Authors:  Ashok Kumar; Shephali Bhatnagar; Pradyut K Paul
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-05       Impact factor: 4.294

Review 5.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

Review 6.  Inhibitor of apoptosis proteins as intracellular signaling intermediates.

Authors:  Andrew J Kocab; Colin S Duckett
Journal:  FEBS J       Date:  2015-11-04       Impact factor: 5.542

7.  Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production.

Authors:  Conor J Kearney; Clare Sheridan; Sean P Cullen; Graham A Tynan; Susan E Logue; Inna S Afonina; Domagoj Vucic; Ed C Lavelle; Seamus J Martin
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

8.  The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms.

Authors:  Pradyut K Paul; Shephali Bhatnagar; Vivek Mishra; Sanjay Srivastava; Bryant G Darnay; Yongwon Choi; Ashok Kumar
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

9.  The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis.

Authors:  Sam I McNeal; Mark P LeGolvan; Chun-Shiang Chung; Alfred Ayala
Journal:  Shock       Date:  2011-05       Impact factor: 3.454

10.  OTUB1 modulates c-IAP1 stability to regulate signalling pathways.

Authors:  Tatiana Goncharov; Kyle Niessen; Maria Cristina de Almagro; Anita Izrael-Tomasevic; Anna V Fedorova; Eugene Varfolomeev; David Arnott; Kurt Deshayes; Donald S Kirkpatrick; Domagoj Vucic
Journal:  EMBO J       Date:  2013-03-22       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.